Kailera Therapeutics, Inc. (KLRA) short interest & options flow
NASDAQKailera Therapeutics has spent September in freefall, and the data heading into October shows bears sitting firmly in control with the next earnings catalyst still six weeks away. The most striking feature of the week is the short score, which tells a consistent story of rising bearish pressure. The ORTEX short score stands at 75.1, its highest reading of the past two weeks and…
KLRA short interest surges 21.3% in one week to 5.6M shares, driven by biotech sector volatility and clinical-stage uncertainty despite recent trial momentum.
- Market cap
- $1.85B
- Next earnings
- 12 Nov 2026
Key data as of 12 Nov 2026
Latest signals on KLRA
- Short Interest
KLRA short interest surges 21.3% in one week to 5.6M shares, driven by biotech sector volatility and clinical-stage uncertainty despite recent trial momentum.
KLRA news and analysis
RSSNo long-form analysis yet for KLRA. Pulse alerts and the live data picture are available on ORTEX.
Open KLRA on ORTEX →Want the live picture for KLRA?
Short interest updated daily, real-time options flow, analyst consensus deltas, 13F positioning, ORTEX Alpha signals, and every article ORTEX publishes for KLRA — free to start on ORTEX.
Sign up for free →Open KLRA on ORTEX